551 related articles for article (PubMed ID: 29428498)
1. The role of gut microbiota in Clostridium difficile infection.
Samarkos M; Mastrogianni E; Kampouropoulou O
Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498
[TBL] [Abstract][Full Text] [Related]
2. Microbiologic factors affecting Clostridium difficile recurrence.
Chilton CH; Pickering DS; Freeman J
Clin Microbiol Infect; 2018 May; 24(5):476-482. PubMed ID: 29208562
[TBL] [Abstract][Full Text] [Related]
3. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
4. Exploring ways to improve CDI outcomes.
Galpérine T; Guery B;
Med Mal Infect; 2018 Feb; 48(1):10-17. PubMed ID: 29336930
[TBL] [Abstract][Full Text] [Related]
5. Update of treatment algorithms for Clostridium difficile infection.
Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
[TBL] [Abstract][Full Text] [Related]
6. The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with
Džunková M; D'Auria G; Xu H; Huang J; Duan Y; Moya A; Kelly CP; Chen X
Front Cell Infect Microbiol; 2016; 6():119. PubMed ID: 27757389
[TBL] [Abstract][Full Text] [Related]
7. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of
Eliakim-Raz N; Bishara J
Hum Vaccin Immunother; 2019; 15(6):1453-1456. PubMed ID: 29781761
[TBL] [Abstract][Full Text] [Related]
9. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection.
Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW
BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
[TBL] [Abstract][Full Text] [Related]
11.
Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
[TBL] [Abstract][Full Text] [Related]
12. Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Carlucci C; Petrof EO; Allen-Vercoe E
EBioMedicine; 2016 Nov; 13():37-45. PubMed ID: 27720396
[TBL] [Abstract][Full Text] [Related]
13. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
Piekarska A; Panasiuk A; Stępień PM
Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
[TBL] [Abstract][Full Text] [Related]
14. Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection.
Zuo T; Wong SH; Cheung CP; Lam K; Lui R; Cheung K; Zhang F; Tang W; Ching JYL; Wu JCY; Chan PKS; Sung JJY; Yu J; Chan FKL; Ng SC
Nat Commun; 2018 Sep; 9(1):3663. PubMed ID: 30202057
[TBL] [Abstract][Full Text] [Related]
15. Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?
Khoruts A
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):435-438. PubMed ID: 29667436
[No Abstract] [Full Text] [Related]
16. Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection.
Jalanka J; Mattila E; Jouhten H; Hartman J; de Vos WM; Arkkila P; Satokari R
BMC Med; 2016 Oct; 14(1):155. PubMed ID: 27724956
[TBL] [Abstract][Full Text] [Related]
17. Clostridium difficile infection and intestinal microbiota interactions.
Rodriguez C; Taminiau B; Van Broeck J; Delmée M; Daube G
Microb Pathog; 2015 Dec; 89():201-9. PubMed ID: 26549493
[TBL] [Abstract][Full Text] [Related]
18. Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.
Ianiro G; Valerio L; Masucci L; Pecere S; Bibbò S; Quaranta G; Posteraro B; Currò D; Sanguinetti M; Gasbarrini A; Cammarota G
Clin Microbiol Infect; 2017 May; 23(5):337.e1-337.e3. PubMed ID: 28057560
[TBL] [Abstract][Full Text] [Related]
19. Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients.
Bruno G; Gagliardi A; Oliva A; Trancassini M; Macone A; Cicerone C; D'Abramo A; Iebba V; Auria S; Bonfiglio G; Zingaropoli MA; D'Ettorre G; Badiali D; Vullo V; Corazziari ES; Schippa S
New Microbiol; 2019 Oct; 42(4):221-224. PubMed ID: 31609455
[TBL] [Abstract][Full Text] [Related]
20. Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
Borgia G; Maraolo AE; Foggia M; Buonomo AR; Gentile I
Expert Opin Biol Ther; 2015 Jul; 15(7):1001-14. PubMed ID: 26063385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]